Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting. The study, published today in the peer-reviewed journal Cell Reports, could lead to improved treatments for soft-tissue sarcomas.
After two and a half years of living through the COVID-19 pandemic, the upcoming long weekend can feel like a respite from the constant stress, says Itai Danovitch, MD, MBA, chair of Cedars-Sinai’s Department of Psychiatry and Behavioral Neurosciences.
The Cedars-Sinai Accelerator is welcoming 10 health-tech startup companies from around the world to its eighth accelerator class. The companies are building a variety of healthcare solutions—from culturally-appropriate digital mental health services to wearable devices that help patients manage chronic asthma.
Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research—including late-breaking science—during the European Society of Cardiology Congress 2022, taking place in person and virtually Aug. 26-29.
Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the initial infection.
For the past two-plus years, the COVID-19 pandemic has disrupted children’s education and frustrated parents. Today, with the back-to-school season in full swing, Suzanne Silverstein, MA, ART, founding director of Cedars-Sinai Share & Care, and Rose Bisellach, RN, nurse manager in the Providence Cedars-Sinai Tarzana Medical Center Emergency Room, give their best advice for starting a successful school year.
Nunzio Bottini, MD, PhD, whose groundbreaking research focuses on the role of a group of proteins in the development of rheumatic diseases, has joined Cedars-Sinai as the inaugural director of the Kao Autoimmunity Institute.
Cedars-Sinai investigators have developed a method to help identify which human gut microbes are most likely to contribute to a slew of inflammatory diseases like obesity, liver disease, inflammatory bowel disease, cancer and some neurological diseases.
The majority of people who were likely infected with the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, didn’t know they had the virus, according to a new study from Cedars-Sinai investigators. The findings are published in JAMA Network Open.
Russell Secker, now 67, was in Lake Tahoe in 2016 to run a series of ultra-distance races with his wife, Claire. The two had completed hundreds of marathons and races totaling thousands of miles. But this time was different. A terrible headache and shortness of breath took Russell, a native of England, out of the running.
As baseball heads into the final weeks of the regular season, Cedars-Sinai has opened a special exhibit, "Take Me Out to the Ball Game, 100+ Years of Baseball Movies & Entertainment." It features hand-drawn posters of classic baseball-themed movies and, in all, consists of 35 items.
Marc Botnick, MD, a board-certified radiation oncologist with more than 20 years of experience managing all cancer types, has been named regional medical director for Radiation Oncology at Cedars-Sinai Cancer. His primary clinical practice site will be at Cedars-Sinai Tarzana Radiation Oncology, but he will work closely with physicians throughout the enterprise.
A new report on lung transplantation success rates confirms that Cedars-Sinai patients experienced one-year survival outcomes of 91.49%, an achievement above the national average of 89.46%.
When it comes to COVID-19 immunity, antibodies do not tell the whole story, according to Cedars-Sinai professor of Medicine Stanley C. Jordan, MD.
Adelynn Garza knows a thing or two about beating the odds.
- Cedars-Sinai는 U.S. News & World Report의 "최우수 병원 2022-23("Best Hospitals 2022-23") 순위에서 미국 내 2위, 캘리포니아 지역 1위로 선정되었다. 영향력이 큰 연간 분석에서도 Cedars-Sinai는 로스앤젤레스 지역 병원 순위 1위를 기록했다. U.S. News 순위는 환자 치료 결과, 환자들의 경험, 기술, 평판(설문에 참여한 의사들의 평가에 따름)을 비롯해 다양한 건강 관련 지표를 기준으로 한다.
Alexis Simpkins, MD, PhD, a stroke expert whose research focuses on acute stroke treatment and prevention, advanced brain imaging, and improving health equity in patient care and diversity among trainees in stroke, has joined the faculty in the Department of Neurology at Cedars-Sinai as director of Vascular Neurology Research and the Stroke RNA, Imaging, and Protein Predictors for Patient Tailored Treatments (SkRIPT) Program.
Cedars-Sinai investigators have created bio-realistic and complex computer models of individual brain cells—in unparalleled quantity. Their research, published today in the peer-reviewed journal Cell Reports, details how these models could one day answer questions about neurological disorders—and even human intellect—that aren’t possible to explore through biological experiments.
Ever since Corey Walker, MD, became a spine surgeon, the traditional measure of success focused on how well a patient was able to walk, bend or move after spine surgery. Now, with the help of artificial intelligence, Walker is measuring success differently.
Cedars-Sinai Guerin Children's will welcome its first patients on Monday, Aug. 8, to a new pediatric inpatient facility staffed by an expansive network of clinical experts, who will provide primary and specialty care for children and families.
Cedars-Sinai’s new director of Obesity Medicine in the Department of Surgery, Amanda Velazquez, MD, is determined to help prevent and treat Type 2 diabetes and obesity in the Latinx community.
Investigators at Cedars-Sinai and the University of California, San Francisco (UCSF) have identified a component in the intestine that plays a critical role in repairing damaged tissue.
Holly Hammond faced one of the toughest-imaginable breast cancer scenarios. Her cancer was already advanced and had spread to her liver and lymph nodes when she discovered a tumor on her right breast. The tumor was negative for all of the markers that respond to targeted therapies for cancer treatment. She was also positive for the genes that mark her as especially prone to breast cancer.
Investigators from Cedars-Sinai Cancer have identified genetic signatures that could predict whether tumors in patients with bladder and other cancers will respond to immunotherapy. Their results, published today in the peer-reviewed Journal of the National Cancer Institute, could one day help guide clinicians to the most effective treatments for cancer patients.
Women between 40 and 60 years old are the focus of new national guidelines aimed at preventing unhealthy weight gain that can lead to serious illness. The study review paper and clinical guidelines are published in the Annals of Internal Medicine.
Howard Sandler, MD, chair of the Department of Radiation Oncology at Cedars-Sinai Cancer, has been named president-elect of the American Society for Radiation Oncology (ASTRO). Sandler will begin his term as president-elect in October, followed by single-year terms as president, chair and then immediate past chair of the ASTRO Board.
In a new study, researchers at Cedars-Sinai found that antibiotics have sex-specific effects on the gut microbiome makeup of male and female laboratory rats. The findings, published in the journal Frontiers in Microbiology, could have implications for using the drugs in humans to treat or prevent bacterial infection.
When Arnold Paul was born at Kaspare Cohn Hospital in 1924, no one knew a family tradition was starting.
Hypertension more than doubles the risk of hospitalization related to Omicron infection, even in people who are fully vaccinated and boosted, according to a new study led by investigators in the Smidt Heart Institute at Cedars-Sinai. The findings are published in the journal Hypertension.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Cedars-Sinai Medical Center has awarded a record $36.5 million in grants and sponsorships to nonprofit organizations throughout Los Angeles that are working to improve access to healthcare, civic engagement, social determinants of health and other nonmedical factors that influence health outcomes.
When Jason Lozada, 19, would open the medicine chest in his family’s shared bathroom, he would be concerned about the number of prescription bottles for his father, Vicente Lozada, 54, lining the shelves.
Physician-scientists from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available for media interviews during the Alzheimer’s Association International Conference (AAIC) taking place online and in person July 31-Aug. 4, 2022, in San Diego.
Cedars-Sinai has been named the #2 hospital in the nation and #1 in California in U.S. News & World Report’s "Best Hospitals 2022-23" rankings.
A team from the Smidt Heart Institute and Division of Artificial Intelligence in Medicine at Cedars-Sinai will establish a new program to develop data tools that will help predict which patients could experience heart attacks, heart failure and other cardiac conditions, thanks to a $7 million Outstanding Investigator Award from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.
Two physician leaders from the Cedars-Sinai Comprehensive Transplant Center have been honored by two prestigious national groups.
Inside the new, 23,000-square-foot Guerin Children’s, walls are painted in cheerful yellows, greens and blues. Artificial skylights are timed to brighten and darken as the sun rises and sets. Interactive-art installations feature whimsical characters, and a playroom and family lounge area contribute to the playful energy of the space.
While many 21-year-olds celebrate their coming of age in bars and nightclubs, Andrew Solis is celebrating freedom by finally going home—equipped with a new heart and liver—after nearly eight months at Cedars-Sinai.
David M. Wrigley has been promoted to executive vice president and chief financial officer of Cedars-Sinai Health System, effective July 1.
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.
Investigators from Cedars-Sinai will present the latest novel stem cell and regenerative medicine research at the International Society for Stem Cell Research (ISSCR) Annual Meeting, which is being held in person and virtually June 15-19 in San Francisco.
Investigators from the Women’s Guild Lung Institute at Cedars-Sinai have discovered that zinc, a common mineral, may reverse lung damage and improve survival for patients with a deadly age-related condition known as idiopathic pulmonary fibrosis (IPF).
Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.
Experts from Cedars-Sinai Cancer are available to comment on the American Association for Cancer Research (AACR) Cancer Disparities Progress Report 2022, which will be released Wednesday, June 8, in a virtual congressional briefing. The report highlights the need to increase diversity in clinical trials and the cancer workforce, and it provides policy recommendations for addressing cancer disparities—all areas Cedars-Sinai Cancer is working to address.
Recently, Michael Wulfe, who is 61 and lives in West Hollywood, was on the phone with his sister, Stephanie Wulfe, in Dallas. They talk at least once a day, but that day, something wasn’t right. “I was talking, and then I didn’t have the words,” Wulfe said. “My sister immediately said, ‘Call Cedars-Sinai!’”
Michael Bowdish, MD, MS, a national leader in cardiac surgery and among a handful of cardiac surgeons continuously funded by the National Institutes of Health for a decade, has been appointed vice chair of the Department of Cardiac Surgery in the Smidt Heart Institute.
Cedars-Sinai clinicians and scientists, including anti-rejection therapy pioneer Stanley Jordan, MD, will share their latest advances in research at the American Transplant Congress (ATC), June 4-8, 2022, in Boston. The ATC is the joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.
Results of a Phase II clinical trial led by Cedars-Sinai Cancer investigators indicate that an immunotherapy drug combination could extend the lives of those diagnosed with advanced non-small cell lung cancer, one of the most common forms of lung cancer. The research was presented today during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, with simultaneous publication in the peer-reviewed Journal of Clinical Oncology.
Physicians and scientists from Cedars-Sinai will discuss the latest advances in treatment, care and research at the Endocrine Society’s annual meeting (ENDO 2022) in Atlanta, June 11-14.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
